nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Penicillamine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Penicillamine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Penicillamine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Penicillamine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Penicillamine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Penicillamine—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Penicillamine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Penicillamine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Penicillamine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Penicillamine—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Penicillamine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Penicillamine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Penicillamine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Penicillamine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Penicillamine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Penicillamine—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Penicillamine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Penicillamine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Penicillamine—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Penicillamine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Penicillamine—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Penicillamine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Penicillamine—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Penicillamine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Penicillamine—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Penicillamine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Penicillamine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Penicillamine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Penicillamine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Penicillamine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Penicillamine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Penicillamine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Penicillamine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Penicillamine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Penicillamine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Penicillamine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Penicillamine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Penicillamine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Penicillamine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Penicillamine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Penicillamine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Penicillamine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Penicillamine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Penicillamine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Penicillamine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Penicillamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Penicillamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Penicillamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Penicillamine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Penicillamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Penicillamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Penicillamine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Penicillamine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Penicillamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Penicillamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Penicillamine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Penicillamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Penicillamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Penicillamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Penicillamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Penicillamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Penicillamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Penicillamine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Penicillamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Penicillamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Penicillamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Penicillamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Rash—Topotecan—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Penicillamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Penicillamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000999	0.000999	CcSEcCtD
Penicillamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000998	0.000998	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000984	0.000984	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Penicillamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Penicillamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Penicillamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.000962	CcSEcCtD
Penicillamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000961	0.000961	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000955	0.000955	CcSEcCtD
Penicillamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Penicillamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Penicillamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Penicillamine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000936	0.000936	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Penicillamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000923	0.000923	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000918	0.000918	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Penicillamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000903	0.000903	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000901	0.000901	CcSEcCtD
Penicillamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000898	0.000898	CcSEcCtD
Penicillamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000897	0.000897	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000889	0.000889	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000884	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000866	0.000866	CcSEcCtD
Penicillamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Penicillamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Penicillamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Penicillamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000826	0.000826	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.000823	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000821	0.000821	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00082	0.00082	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000818	0.000818	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000814	0.000814	CcSEcCtD
Penicillamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000802	0.000802	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Penicillamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00078	0.00078	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000779	0.000779	CcSEcCtD
Penicillamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Penicillamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Penicillamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000764	0.000764	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000759	0.000759	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000757	0.000757	CcSEcCtD
Penicillamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000755	0.000755	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000749	CcSEcCtD
Penicillamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000746	0.000746	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Penicillamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Penicillamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000736	0.000736	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000735	0.000735	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000731	CcSEcCtD
Penicillamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000709	0.000709	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.000697	CcSEcCtD
Penicillamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000696	0.000696	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000693	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00068	0.00068	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00068	0.00068	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000662	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Penicillamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000653	0.000653	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000647	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Penicillamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000616	0.000616	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000608	CcSEcCtD
Penicillamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Penicillamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.0006	0.0006	CcSEcCtD
Penicillamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000599	0.000599	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000584	CcSEcCtD
Penicillamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000555	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000428	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Penicillamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Penicillamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Penicillamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000293	CcSEcCtD
